Nastech Pharmaceutical Company Inc - SWOT Analysis

Nastech Pharmaceutical Company Inc - SWOT Analysis
  • Report price : $ 125
  • Publication date : April 2008
  • Length : 25 pages

Get this Report Now !

Nastech Pharmaceutical Company Inc - SWOT Analysis

Datamonitor's Nastech Pharmaceutical Company Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Nastech Pharmaceutical (Nastech) is engaged in a variety of preclinical and clinical research and development activities to identify and develop viable product candidates in therapeutic areas, including osteoporosis, obesity, diabetes, autism, antivirals, inflammation and metabolic diseases. Nastech is headquartered in Bothell, Washington and employs 197 people as of December 2006. *The company recorded revenues of $18.1 million during the fiscal year ended December 2007, a decrease of 36.3% compared to 2006. The operating loss of the company was $54.5 million during fiscal year 2007, as compared to an operating loss of $29.3 million in 2006. The net loss was $52.4 million in fiscal year 2007, as compared to the net loss of $26.9 million in 2006. *Unaudited results

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

Pfizer Inc - SWOT Analysis

Pfizer Inc - SWOT Analysis

  • $ 125
  • April 2008
  • 45 pages

Datamonitor's Pfizer Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Pfizer, ...

Industries : Pharmaceutical | Countries : USA

Santarus, Inc. - SWOT Analysis

Santarus, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 23 pages

Datamonitor's Santarus, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Sant ...

Industries : Pharmaceutical | Countries : USA

Amgen Inc. - SWOT Analysis

Amgen Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 37 pages

Datamonitor's Amgen Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Amgen is ...

Industries : Pharmaceutical | Countries : USA

ISTA Pharmaceuticals, Inc. - SWOT Analysis

ISTA Pharmaceuticals, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 24 pages

Datamonitor's ISTA Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...

Industries : Pharmaceutical | Countries : USA

Cardinal Health, Inc. - SWOT Analysis

Cardinal Health, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 39 pages

Datamonitor's Cardinal Health, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strateg ...

Industries : Pharmaceutical | Countries : USA

CollaGenex Pharmaceuticals, Inc. - SWOT Analysis

CollaGenex Pharmaceuticals, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 25 pages

Datamonitor's CollaGenex Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines ...

Industries : Pharmaceutical | Countries : USA

Biogen Idec, Inc. - SWOT Analysis

Biogen Idec, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 27 pages

Datamonitor's Biogen Idec, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. B ...

Industries : Pharmaceutical | Countries : USA

Insulin Delivery Systems Market Analysis (2007-2010)

Insulin Delivery Systems Market Analysis (2007-2010)

  • $ 1 400
  • January 2008
  • 250 pages

The research report “Insulin Delivery Systems Market Analysis (2007-2010)” by RNCOS gives an exhaustive analysis on the global insulin market and various Insulin delivery methods. The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, ...

Industries : Medical Devices, Pharmaceutical | Countries : Egypt, Mexico, Brazil, USA, China, Japan, India, Pakistan, Russia, Germany

Live-Licensing and In-life testing: R and D Processes and Regulation for New Drugs, 2008-2020

Live-Licensing and In-life testing: R and D Processes and Regulation for New Drugs, 2008-2020

  • $ 2 501
  • January 2008
  • 250 pages

Visiongain predict that the current phase I to IV clinical testing process will eventually be selectively or wholly replaced by a system known as “in-life” testing or “live” licensing. Those proposals involve cumulative testing of the drug throughout its lifecycle. The industry would continu ...

Industries : Pharmaceutical | Countries : USA, Japan, Germany, United Kingdom

Sleep Disorders Market Analysis 2008-2018

Sleep Disorders Market Analysis 2008-2018

  • $ 2 501
  • March 2008
  • 250 pages

More than 80 sleep disorders have been identified. They affect over 200 million people worldwide. The report focuses on the market for following sleep disorders: Insomnia Restless legs syndrome (RLS) Narcolepsy and Obstructive Sleep Apnoea / Hypopnea Syndrome (OSAHS) The market penetration for insom ...

Industries : Pharmaceutical | Countries : USA, Japan, Germany, Spain, France, Italy, United Kingdom

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.